Copyright (c) 2026 Documentos de trabajo ECISA

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Natural products against Candida albicans: experimental and clinical evidence in the context of vulvovaginal candidiasis
Objective. To critically analyze the scientific evidence on the antifungal activity of natural products against Candida albicans, considering experimental findings, clinical evidence, and their therapeutic potential for vulvovaginal candidiasis.
Methods. A literature review was conducted following the PRISMA 2020 reporting guidelines. The search was performed in Dialnet, SciELO, and Google Scholar, covering publications from 2000 to 2024. Of the 1,006 records identified, 13 original studies were included: eight experimental and five clinical studies. A descriptive synthesis of their methodologies, findings, and limitations was performed.
Results. Experimental studies demonstrated antifungal activity of various natural products, particularly Allium sativum (garlic), including against nystatin-resistant vaginal isolates, and Origanum vulgare. However, differences in extracts, concentrations, and experimental methods limited comparability across studies. Clinical investigations reported variable improvements with certain natural formulations, but the available evidence was insufficient to establish therapeutic equivalence with conventional antifungal treatments.
Conclusions. Natural products represent a promising source of compounds with antifungal activity against C. albicans. Nevertheless, their clinical application requires stronger evidence of efficacy and safety through standardized extracts, cytotoxicity assessments, and well-controlled clinical trials.